ORM-12741 has been used in trials studying the basic science and treatment of Alzheimer's Disease.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Norepinephrine | ORM-12741 may decrease the hypertensive activities of Norepinephrine. |
| Epinephrine | ORM-12741 may decrease the hypertensive activities of Epinephrine. |
| Droxidopa | ORM-12741 may decrease the hypertensive activities of Droxidopa. |
| Levonordefrin | ORM-12741 may decrease the hypertensive activities of Levonordefrin. |
| Protokylol | ORM-12741 may decrease the hypertensive activities of Protokylol. |
| Racepinephrine | ORM-12741 may decrease the hypertensive activities of Racepinephrine. |
| Theodrenaline | ORM-12741 may decrease the hypertensive activities of Theodrenaline. |
| Deoxyepinephrine | ORM-12741 may decrease the hypertensive activities of Deoxyepinephrine. |
| Ephedrine | ORM-12741 may decrease the hypertensive activities of Ephedrine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with ORM-12741. |
| Bethanidine | The therapeutic efficacy of Bethanidine can be decreased when used in combination with ORM-12741. |
| Isoetharine | The therapeutic efficacy of Isoetharine can be decreased when used in combination with ORM-12741. |
| Etomidate | The therapeutic efficacy of Etomidate can be decreased when used in combination with ORM-12741. |
| Phenylephrine | The therapeutic efficacy of Phenylephrine can be decreased when used in combination with ORM-12741. |
| Phenylpropanolamine | The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with ORM-12741. |
| Clonidine | The therapeutic efficacy of Clonidine can be decreased when used in combination with ORM-12741. |
| Metaraminol | The therapeutic efficacy of Metaraminol can be decreased when used in combination with ORM-12741. |
| Guanabenz | The therapeutic efficacy of Guanabenz can be decreased when used in combination with ORM-12741. |
| Dexmedetomidine | The therapeutic efficacy of Dexmedetomidine can be decreased when used in combination with ORM-12741. |
| Tizanidine | The therapeutic efficacy of Tizanidine can be decreased when used in combination with ORM-12741. |
| Methoxamine | The therapeutic efficacy of Methoxamine can be decreased when used in combination with ORM-12741. |
| Orciprenaline | The therapeutic efficacy of Orciprenaline can be decreased when used in combination with ORM-12741. |
| Dobutamine | The therapeutic efficacy of Dobutamine can be decreased when used in combination with ORM-12741. |
| Ritodrine | The therapeutic efficacy of Ritodrine can be decreased when used in combination with ORM-12741. |
| Terbutaline | The therapeutic efficacy of Terbutaline can be decreased when used in combination with ORM-12741. |
| Bitolterol | The therapeutic efficacy of Bitolterol can be decreased when used in combination with ORM-12741. |
| Oxymetazoline | The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with ORM-12741. |
| Salmeterol | The therapeutic efficacy of Salmeterol can be decreased when used in combination with ORM-12741. |
| Methyldopa | The therapeutic efficacy of Methyldopa can be decreased when used in combination with ORM-12741. |
| Formoterol | The therapeutic efficacy of Formoterol can be decreased when used in combination with ORM-12741. |
| Albuterol | The therapeutic efficacy of Salbutamol can be decreased when used in combination with ORM-12741. |
| Guanfacine | The therapeutic efficacy of Guanfacine can be decreased when used in combination with ORM-12741. |
| Isoprenaline | The therapeutic efficacy of Isoprenaline can be decreased when used in combination with ORM-12741. |
| Arbutamine | The therapeutic efficacy of Arbutamine can be decreased when used in combination with ORM-12741. |
| Pergolide | The therapeutic efficacy of Pergolide can be decreased when used in combination with ORM-12741. |
| Bromocriptine | The therapeutic efficacy of Bromocriptine can be decreased when used in combination with ORM-12741. |
| Ergometrine | The therapeutic efficacy of Ergometrine can be decreased when used in combination with ORM-12741. |
| Arformoterol | The therapeutic efficacy of Arformoterol can be decreased when used in combination with ORM-12741. |
| Fenoterol | The therapeutic efficacy of Fenoterol can be decreased when used in combination with ORM-12741. |
| Pirbuterol | The therapeutic efficacy of Pirbuterol can be decreased when used in combination with ORM-12741. |
| Ephedra sinica root | The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with ORM-12741. |
| Procaterol | The therapeutic efficacy of Procaterol can be decreased when used in combination with ORM-12741. |
| Clenbuterol | The therapeutic efficacy of Clenbuterol can be decreased when used in combination with ORM-12741. |
| Bambuterol | The therapeutic efficacy of Bambuterol can be decreased when used in combination with ORM-12741. |
| 4-Methoxyamphetamine | The therapeutic efficacy of 4-Methoxyamphetamine can be decreased when used in combination with ORM-12741. |
| 4-Bromo-2,5-dimethoxyphenethylamine | The therapeutic efficacy of 4-Bromo-2,5-dimethoxyphenethylamine can be decreased when used in combination with ORM-12741. |
| Celiprolol | The therapeutic efficacy of Celiprolol can be decreased when used in combination with ORM-12741. |
| Nebivolol | The therapeutic efficacy of Nebivolol can be decreased when used in combination with ORM-12741. |
| Lofexidine | The therapeutic efficacy of Lofexidine can be decreased when used in combination with ORM-12741. |
| Indacaterol | The therapeutic efficacy of Indacaterol can be decreased when used in combination with ORM-12741. |
| Amibegron | The therapeutic efficacy of Amibegron can be decreased when used in combination with ORM-12741. |
| Nylidrin | The therapeutic efficacy of Nylidrin can be decreased when used in combination with ORM-12741. |
| Solabegron | The therapeutic efficacy of Solabegron can be decreased when used in combination with ORM-12741. |
| Xylometazoline | The therapeutic efficacy of Xylometazoline can be decreased when used in combination with ORM-12741. |
| Isometheptene | The therapeutic efficacy of Isometheptene can be decreased when used in combination with ORM-12741. |
| Naphazoline | The therapeutic efficacy of Naphazoline can be decreased when used in combination with ORM-12741. |
| Tetryzoline | The therapeutic efficacy of Tetryzoline can be decreased when used in combination with ORM-12741. |
| Mirabegron | The therapeutic efficacy of Mirabegron can be decreased when used in combination with ORM-12741. |
| Adrafinil | The therapeutic efficacy of Adrafinil can be decreased when used in combination with ORM-12741. |
| Isoxsuprine | The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with ORM-12741. |
| Hexoprenaline | The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with ORM-12741. |
| Etilefrine | The therapeutic efficacy of Etilefrine can be decreased when used in combination with ORM-12741. |
| Olodaterol | The therapeutic efficacy of Olodaterol can be decreased when used in combination with ORM-12741. |
| Vilanterol | The therapeutic efficacy of Vilanterol can be decreased when used in combination with ORM-12741. |
| Cirazoline | The therapeutic efficacy of Cirazoline can be decreased when used in combination with ORM-12741. |
| Synephrine | The therapeutic efficacy of Synephrine can be decreased when used in combination with ORM-12741. |
| Moxonidine | The therapeutic efficacy of Moxonidine can be decreased when used in combination with ORM-12741. |
| Doxofylline | The therapeutic efficacy of Doxofylline can be decreased when used in combination with ORM-12741. |
| DL-Methylephedrine | The therapeutic efficacy of DL-Methylephedrine can be decreased when used in combination with ORM-12741. |
| Amitraz | The therapeutic efficacy of Amitraz can be decreased when used in combination with ORM-12741. |
| Medetomidine | The therapeutic efficacy of Medetomidine can be decreased when used in combination with ORM-12741. |
| Xylazine | The therapeutic efficacy of Xylazine can be decreased when used in combination with ORM-12741. |
| Ractopamine | The therapeutic efficacy of Ractopamine can be decreased when used in combination with ORM-12741. |
| Romifidine | The therapeutic efficacy of Romifidine can be decreased when used in combination with ORM-12741. |
| Detomidine | The therapeutic efficacy of Detomidine can be decreased when used in combination with ORM-12741. |
| Etafedrine | The therapeutic efficacy of Etafedrine can be decreased when used in combination with ORM-12741. |
| Rilmenidine | The therapeutic efficacy of Rilmenidine can be decreased when used in combination with ORM-12741. |
| Anisodamine | The therapeutic efficacy of Anisodamine can be decreased when used in combination with ORM-12741. |
| PF-00610355 | The therapeutic efficacy of PF-00610355 can be decreased when used in combination with ORM-12741. |
| Abediterol | The therapeutic efficacy of Abediterol can be decreased when used in combination with ORM-12741. |
| Tulobuterol | The therapeutic efficacy of Tulobuterol can be decreased when used in combination with ORM-12741. |
| Dopexamine | The therapeutic efficacy of Dopexamine can be decreased when used in combination with ORM-12741. |
| Batefenterol | The therapeutic efficacy of Batefenterol can be decreased when used in combination with ORM-12741. |
| Higenamine | The therapeutic efficacy of Higenamine can be decreased when used in combination with ORM-12741. |
| Reproterol | The therapeutic efficacy of Reproterol can be decreased when used in combination with ORM-12741. |
| Levosalbutamol | The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with ORM-12741. |
| Octopamine | The therapeutic efficacy of Octopamine can be decreased when used in combination with ORM-12741. |
| Norfenefrine | The therapeutic efficacy of Norfenefrine can be decreased when used in combination with ORM-12741. |
| Oxyfedrine | The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with ORM-12741. |
| Rimiterol | The therapeutic efficacy of Rimiterol can be decreased when used in combination with ORM-12741. |
| Tretoquinol | The therapeutic efficacy of Tretoquinol can be decreased when used in combination with ORM-12741. |
| Prenalterol | The therapeutic efficacy of Prenalterol can be decreased when used in combination with ORM-12741. |
| Xamoterol | The therapeutic efficacy of Xamoterol can be decreased when used in combination with ORM-12741. |
| Racephedrine | The therapeutic efficacy of Racephedrine can be decreased when used in combination with ORM-12741. |
| Amidephrine | The therapeutic efficacy of Amidephrine can be decreased when used in combination with ORM-12741. |
| Phendimetrazine | The therapeutic efficacy of ORM-12741 can be decreased when used in combination with Phendimetrazine. |
| Amphetamine | The therapeutic efficacy of ORM-12741 can be decreased when used in combination with Amphetamine. |
| Phentermine | The therapeutic efficacy of ORM-12741 can be decreased when used in combination with Phentermine. |
| Pseudoephedrine | The therapeutic efficacy of ORM-12741 can be decreased when used in combination with Pseudoephedrine. |
| Benzphetamine | The therapeutic efficacy of ORM-12741 can be decreased when used in combination with Benzphetamine. |